This adjustment is primarily related to the acquisition of Morphic Holdings, which impacted in-process research and development charges by $3.09 billion, or $3.33 per share. For the third quarter ...

Morphic Holding is focused on inflammatory bowel disease, a market worth roughly $22 billion, and is expected to grow at a ...

Adding to the quarterly woes, a $2.8 billion charge related to the acquisition of Morphic Holding dented results further. Analysts responded to the mixed earnings by revising their outlook on Eli ...

Sifting through countless of stocks in the Biotechnology industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has announced a daily update on its ongoing buy-back program, with 30,232 ordinary fully paid ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has announced a daily update on their ongoing on-market buy-back, with a total of 7,884 ...

Jim Cramer is Talking About These 7 Stocks Jim Cramer is Talking About These 7 Stocks Our Methodology For this article, we compiled a list of 7 stocks that were discussed by Jim Cramer during the ...